Literature DB >> 34037165

Vertical transmission and COVID-19: a scoping review.

Karoline Faria de Oliveira1, Jacqueline Faria de Oliveira2, Monika Wernet3, Marina Carvalho Paschoini1, Mariana Torreglosa Ruiz1.   

Abstract

OBJECTIVE: Analyze available evidence related to SARS-CoV-2 infection and vertical transmission.
METHODS: Scoping review, according to the Joanna Briggs Institute and PRISMA-ScR. Searches were conducted in five electronic databases to find publications about coronavirus infection and vertical transmission. Data were extracted, analyzed and synthesized by three independent researchers using a descriptive approach.
RESULTS: The search resulted in 76 publications. After selective steps, 15 articles - retrospective descriptive or case studies - were analyzed, all in English. In order to track the infection, specimens were collected from neonates through nasal swabs and C-reactive protein from breast milk, cord blood, amniotic fluid, placenta and vaginal secretion was analyzed. A small percentage of neonates tested positive for COVID-19, but these cases were not attributed to vertical transmission.
CONCLUSION: Vertical transmission could not be demonstrated. Research protocol registered with the Open Science Framework (https://osf.io/fawmv).

Entities:  

Year:  2021        PMID: 34037165     DOI: 10.1590/0034-7167-2020-0849

Source DB:  PubMed          Journal:  Rev Bras Enferm        ISSN: 0034-7167


  3 in total

Review 1.  Effects of Vertical Transmission of Respiratory Viruses to the Offspring.

Authors:  Sara Manti; Salvatore Leonardi; Fariba Rezaee; Terri J Harford; Miriam K Perez; Giovanni Piedimonte
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 8.786

Review 2.  Epidemiology of COVID-19: What changed in one year?

Authors:  Cemal Bulut; Yasuyuki Kato
Journal:  Turk J Med Sci       Date:  2021-12-17       Impact factor: 0.973

Review 3.  Neuropathogenesis of severe acute respiratory syndrome coronavirus 2.

Authors:  Payal B Patel; David Bearden
Journal:  Curr Opin Pediatr       Date:  2021-12-01       Impact factor: 2.856

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.